Publication:
Transforming growth factor-β1 gene polymorphism as a potential risk factor in Turkish patients with laryngeal squamous cell carcinoma

dc.contributor.buuauthorAbakay, Candan Demiroz
dc.contributor.buuauthorDEMİRÖZ ABAKAY, CANDAN
dc.contributor.buuauthorPashazadeh, Mehrdad
dc.contributor.buuauthorArdahanli, Elif
dc.contributor.buuauthorOral, Haluk Barbaros
dc.contributor.buuauthorORAL, HALUK BARBAROS
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentOnkoloji Ana Bilim Dalı
dc.contributor.orcid0000-0001-9103-6276
dc.contributor.orcid0000-0003-0463-6818
dc.contributor.researcheridK-7285-2012
dc.contributor.researcheridAAH-3855-2021
dc.date.accessioned2024-07-02T07:33:57Z
dc.date.available2024-07-02T07:33:57Z
dc.date.issued2020-01-01
dc.description.abstractIntroduction: Laryngeal cancer is the most common head-and-neck malignancies with more than 20% of all cases. The vast majority of tumors are squamous cell carcinoma (SCC). Several genes encoding different cytokines may play crucial roles in host susceptibility to cancer because cytokine production capacity varies among individuals and depends on cytokine gene polymorphisms. Materials and Methods: The association between cytokine gene polymorphisms with primary laryngeal SCC was investigated. DNA samples were obtained from a Turkish population of eighty patients with primary cancer and fifty healthy controls. Results: All genotyping (interferon-gamma, transforming growth factor-beta 1 [TGF-beta 1], tumor necrosis factor-alpha [TNF-alpha], interleukin [IL]-6, and IL-10) experiments were performed using polymerase chain reaction sequence-specific primers. When compared to the healthy controls, the frequencies of TGF-beta 1 codon 25 (rs1800471) GC genotype and 25 C allele were significantly more common in the patient group. Conclusions: These results suggest that TGF-beta 1 gene polymorphisms may affect host susceptibility to laryngeal cancer.
dc.description.sponsorshipTurkish Society for Radiation Oncology
dc.identifier.doi10.4103/jcrt.JCRT_598_19
dc.identifier.endpage149
dc.identifier.issn0973-1482
dc.identifier.issue1
dc.identifier.startpage144
dc.identifier.urihttps://doi.org/10.4103/jcrt.JCRT_598_19
dc.identifier.urihttps://hdl.handle.net/11452/42705
dc.identifier.volume16
dc.identifier.wos000536629700024
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.bapOUAP(T)-2013/25
dc.relation.journalJournal Of Cancer Research And Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGrowth-factor-beta
dc.subjectTgf-beta
dc.subjectCancer-risk
dc.subjectOral-cancer
dc.subjectT-cells
dc.subjectAssociation
dc.subjectTgf-beta-1
dc.subjectSusceptibility
dc.subjectTh17
dc.subjectTobacco
dc.subjectCytokine
dc.subjectGenotyping
dc.subjectLarynx cancer
dc.subjectSingle-nucleotide gene polymorphism
dc.subjectTransforming growth factor-beta
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectOncology
dc.subjectOncology
dc.titleTransforming growth factor-β1 gene polymorphism as a potential risk factor in Turkish patients with laryngeal squamous cell carcinoma
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Onkoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/İmmünoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Mikrobiyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi
relation.isAuthorOfPublication42e5fe2e-88cd-4083-9ed8-28b4cfa73e9d
relation.isAuthorOfPublicationbc853dab-a811-42b9-b03b-6d5fe067efe8
relation.isAuthorOfPublication.latestForDiscovery42e5fe2e-88cd-4083-9ed8-28b4cfa73e9d

Files